Private beta · For researchers at every level

Experimental science at the speed of scientific thought.

Generate complete, publication-quality experimental protocols from your research goal. Materials, controls, statistical guidance, safety notes, and troubleshooting — all included. Built for middle schoolers through PhDs through biotech companies.

End-to-end encryptedSOC 2 readyRow-level data isolationFull audit trail
Secure
Recent
CRISPR-Cas9 Knockout
T-Cell Activation
Drug Synergy Screen
Protocol 001 — Oncology
CRISPR-Cas9 Knockout of KRAS G12C in Pancreatic Ductal Adenocarcinoma Cells
Feasibility
91
Controls
88
Reproducibility
85
Clarity
94
Feasib
91
Contro
88
Reprod
85
Clarit
94

Designed for every scientific discipline

OncologyImmunologyNeuroscienceGenomicsCell BiologyPharmacologyProteomicsClinical ResearchBioengineeringStructural BiologyBiochemistryMicrobiology
2,400+
Protocols generated
this month across all fields
12s
Average generation time
from plain English to complete protocol
99.9%
Uptime SLA
on Lab and Enterprise plans
Platform

Every tool a research lab needs — in one platform.

Built from the ground up for how scientists actually work — from the bench to the boardroom.

AI Protocol Generator

From research goal to complete protocol in seconds.

Describe your objective in plain language. Olto returns a complete experimental design — materials, reagents, controls, statistical plan, safety notes, and troubleshooting guidance. Seven refinement modes let you make it cheaper, faster, more controlled, or suitable for a teaching lab. Every output includes scoring on feasibility, controls, reproducibility, and clarity.

12s
avg generation time
Objective
87
Hypothesis
72
Materials
95
Controls
68
Safety Notes
80
Visual Protocol Designer

Build complex lab workflows step by step.

Seven step types including Decision Gates, Safety Checks, Parallel Blocks, and Measurements. Add duration, temperature, equipment, and expected outcomes to each step. Test run mode lets you execute a protocol live from a phone or tablet in the lab. AI simulation flags risks and estimates cost before you run it.

7
step types + custom tools
Wash cells × 3 PBS
5 min
Incubate primary Ab
60 min / 4°C
📊
Flow cytometry run
🔀
Viability > 85%?
Gate
🛡️
Dispose of fixative
Required
Scientific AI Assistant

A colleague who knows your entire lab history.

Unlike generic AI, the assistant remembers your prior experiments, uploaded papers, and preferences across every conversation. Ask it to interpret results, recommend next experiments, critique your controls, or draft a methods section — with full context from your research history. Powered by Claude Sonnet or Opus depending on your plan.

lab memory
What statistical test for my 3-group comparison with n=8?
Based on your prior ANOVA experiments and n=8 per group, I recommend one-way ANOVA with Tukey post-hoc correction. Your data meets normality assumptions from the Shapiro-Wilk tests in your last two protocols.
Lab Inventory & Tools

Track every reagent, antibody, and instrument.

Full inventory management with low-stock alerts, expiry tracking, lot numbers, storage conditions, and hazard classifications. Build a library of custom step types for lab-specific instruments and workflows. Link inventory to protocols so you can check stock before you start an experiment.

items tracked
Fetal Bovine Serum
250 mL
Anti-CD3 antibody
12 µg
DMEM media
2 L
Trypsin 0.25%
50 mL
Research Stories

How researchers use Olto Discovery.

From middle schoolers doing their first science project to biotech companies designing clinical trials.

SC
Dr. Sarah Chen, PhD
Principal Investigator, Therapeutic Oncology
Dana-Farber Cancer Institute
Oncology
We were spending two to three weeks designing each new experimental arm for our KRAS inhibitor screen. Olto compressed that to an afternoon. The statistical planning alone — power calculations, the multiple comparison corrections — used to require a dedicated biostatistics consultation. Now it's built into every protocol we generate.
Reduced protocol design time from 3 weeks to 4 hours. Ran 6 additional experimental arms in Q1.
MW
Dr. Marcus Webb, MD/PhD
Postdoctoral Fellow, Bhatt Lab
Stanford School of Medicine
Immunology
Olto catches things I'd miss at midnight — isotype controls, housekeeping genes, the right normalization strategy. My PI noticed the protocols looked more rigorous before I even told him I was using it.
First-author manuscript accepted to Nature Immunology. Controls section praised by reviewers.
AP
Dr. Aisha Patel, PhD
Senior Research Scientist, Neuroscience
Genentech Research
Neuroscience
We run a tight lab with high throughput. The AI assistant actually learns our preferences over time. It feels like a very well-read lab manager.
20x increase in protocol throughput. Zero SOC 2 compliance concerns with institutional IT.
JT
James Thornton, MS
Research Associate II, In Vitro Pharmacology
Pfizer Research & Development
Pharmacology
The manual protocol designer is what sold us. I can build proprietary assays step-by-step, flag the critical steps, run the simulation, and have a QC-reviewed document ready for our regulatory team. It replaced a LIMS workflow we were paying six figures for.
Replaced legacy LIMS protocol module. Estimated $120K annual savings.
Security & Compliance

Research data security is not optional.

Built with institutional security requirements as a baseline, not an afterthought. Sensitive IP and patient-adjacent data handled with full compliance.

AES-256 encryption at rest, TLS 1.3 in transit
Row-level security enforced at the database engine level
Full audit log — every action, IP, user, timestamp
Role-based access control with granular permissions
SOC 2 Type II aligned infrastructure
HIPAA-ready on Enterprise with BAA available
🔐
AES-256
Encrypted at rest
🛡️
RLS Policies
Row-level security
📋
Audit Logs
Immutable trail
👥
RBAC
Granular roles
🏛️
SOC 2 Ready
Type II aligned
🏥
HIPAA Ready
Enterprise + BAA
Get started today

Your lab's scientific intelligence starts here.

Free to start. No credit card required. Join researchers from leading universities and biotech companies.